Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gearing, M.
Right arrow Articles by Mirra, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gearing, M.
Right arrow Articles by Mirra, S. S.

Neurology, Vol 45, Issue 11 1985-1990, Copyright © 1995 by American Academy of Neurology


ARTICLES

Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates

M Gearing, JA Schneider, GW Rebeck, BT Hyman and SS Mirra
Veterans Affairs Medical Center, Atlanta, GA, USA.

The frequency of the apolipoprotein E (ApoE) epsilon 4 allele and its relationship with coexistent Parkinson's disease (PD) neuropathology in Alzheimer's disease (AD) have not been extensively explored. We determined ApoE genotype in 100 dementia patients with neuropathologically confirmed AD with and without concomitant Parkinson's disease (PD) changes (nigral degeneration and Lewy bodies at various sites). Fifty "AD+PD" patients were matched closely with 50 "pure AD" patients for age, sex, and duration of dementia. We found identical overrepresentation of the epsilon 4 allele in the two groups: 72% of the patients in each group had at least one ApoE epsilon 4 allele, compared with approximately 25% in the general population (p < 0.005) and in our institutional autopsy population (p < 0.001). Age at onset varied inversely with epsilon 4 allele dosage in men but not in women in both the AD and the AD+PD groups. As with amyloid deposition and plaque frequency in AD, we observed an association between epsilon 4 dosage and PD-related changes. Specifically, the severity of ubiquitin-positive neuritic change in CA2/3 of the hippocampus, but not the frequency of cortical Lewy bodies, varied significantly with epsilon 4 dosage in the AD+PD cases.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Choi, H. D. Rees, S. T. Weintraub, A. I. Levey, L.-S. Chin, and L. Li
Oxidative Modifications and Aggregation of Cu,Zn-Superoxide Dismutase Associated with Alzheimer and Parkinson Diseases
J. Biol. Chem., March 25, 2005; 280(12): 11648 - 11655.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. W. Tsuang, R. K. Wilson, O. L. Lopez, E. K. Luedecking-Zimmer, J. B. Leverenz, S. T. DeKosky, M. I. Kamboh, and R. L. Hamilton
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease
Neurology, February 8, 2005; 64(3): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Choi, A. I. Levey, S. T. Weintraub, H. D. Rees, M. Gearing, L.-S. Chin, and L. Li
Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases
J. Biol. Chem., March 26, 2004; 279(13): 13256 - 13264.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. B. Leverenz, C. M. Agustin, D. Tsuang, E. R. Peskind, S. D. Edland, D. Nochlin, L. DiGiacomo, J. D. Bowen, W. C. McCormick, L. Teri, et al.
Clinical and Neuropathological Characteristics of Hippocampal Sclerosis: A Community-Based Study
Arch Neurol, July 1, 2002; 59(7): 1099 - 1106.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Chapman, A. D. Korczyn, D. M. Karussis, and D. M. Michaelson
The effects of APOE genotype on age at onset and progression of neurodegenerative diseases
Neurology, October 23, 2001; 57(8): 1482 - 1485.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
D. Tsuang, E. B. Larson, J. Bowen, W. McCormick, L. Teri, D. Nochlin, J. B. Leverenz, E. R. Peskind, A. Lim, M. A. Raskind, et al.
The Utility of Apolipoprotein E Genotyping in the Diagnosis of Alzheimer Disease in a Community-Based Case Series
Arch Neurol, December 1, 1999; 56(12): 1489 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Green and A. I. Levey
Event-Related Potential Changes in Groups at Increased Risk for Alzheimer Disease
Arch Neurol, November 1, 1999; 56(11): 1398 - 1403.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L A Hansen, S E Daniel, G K Wilcock, and S Love
Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 653 - 656.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. Berg, D. W. McKeel Jr, J. P. Miller, M. Storandt, E. H. Rubin, J. C. Morris, J. Baty, M. Coats, J. Norton, A. M. Goate, et al.
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Arch Neurol, March 1, 1998; 55(3): 326 - 335.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. F. Beal and J.-P. Vonsattel
Case 7-1998- A 74-Year-Old Man with Dementia, Parkinsonism, and an Insular Lesion
N. Engl. J. Med., February 26, 1998; 338(9): 603 - 610.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.